Sangeeta Shukla

NexCAR19 Marks a New Era: Exploring Promising Cancer Research and the Challenges of Pre-Clinical Trials

Ahmedabad (Gujarat) [India], September 25:   With the recent success of NexCAR19 – India’s first approved CAR-T cell therapy for cancer cure, now is an opportune time to talk about and create more awareness about other upcoming and promising research in cancer treatment. In general, research focused on disease treatment goes through pre-clinical and clinical trial […]

Continue Reading